GASCO, Alberto
GASCO, Alberto
Dip. SCIENZA E TECNOLOGIA DEL FARMACO (attivo dal 01/01/1900 al 30/04/2013)
A multitarget approach to optimize the safety profile of coxibs: lumiracoxib derivatives with dual cyclooxygenase-2 inhibitor-thromboxane A2 receptor antagonist activity
2013-01-01 Malvina Hoxha; Valerie Capra; Carola Buccellati; Angelo Sala; Mohammed Abrar Abdul Gaffar Shaikh; Clara Cena; Roberta Fruttero; Alberto Gasco; G. Enrico Rovati; Massimo Bertinaria
Amphiphile NO-donor antioxidants as polivalent drugs
2006-01-01 MARINI E; LAZZARATO L; CHEGAEV K; FRUTTERO R; GASCO A
Aspects of heterocyclic chemistry in developing new 1,4-dihydropyridines Ca2+-agonists
2000-01-01 S.Visentin; G.Ermondi; D.Boschi; R. Fruttero; A. Gasco
Carnosine analogues containing Phenol substructures
2012-01-01 Giorgis M.; Bertinaria M.; Rolando B.; Montanaro G.; Fruttero R.; Gasco A.
CC1000: a new cardioprotective agent against ischemia/reperfusion injuries
2006-01-01 A. Di Stilo; R. Rastaldo; M. Giorgis; G. Losano; A. Gasco
Combined protective effect of nitric oxide donor and antioxidants in the rat heart
2007-01-01 Rastaldo R; Cappello S; Pagliaro P; Mancardi D; Di Stilo A; Gasco A; Losano G.
Different multitarget approaches to manage coxibs associatedcardiovascular risk. Design and synthesis of new lumiracoxibderivatives
2012-01-01 M. Bertinaria; M. A. A. G. Shaikh; C. Cena; B. Rolando; L. Lazzarato; R. Fruttero; A. Gasco; G. E. Rovati; C. Buccellati; V. Capra; A. Sala
Effetto del post-condizionamento farmacologico sui danni da ischemia e riperfusione
2005-01-01 Rastaldo R.; Di Stilo A.; Cappello S. ; Gasco F.; Pagliaro P.; Gasco A.; Losano G.
Multitarget Drugs: No-Donor Doxorubicins
2015-01-01 Chegaev, Konstantin; Riganti, Chiara; Gazzano, Elena; Rolando, Barbara; Fruttero, Roberta; Gasco, Alberto
Multitarget drugs: NO-donor doxorubicins
2012-01-01 Chegaev K.; Riganti C.; Rolando B.; Federico A.; Fruttero R.; Gasco A.
New analogues of Ca2+-channel activator Bay K8644
2003-01-01 S. Visentin; F. Buonsanti; M. Novara; E. Carbone; A. Gasco
New NO-donor Bisphosphonates
2001-01-01 L. LAZZARATO; LOLLI M.L; DI STILO A; FRUTTERO R; GASCO A
New potent and selective P-gp inhibitors
2013-01-01 Guglielmo S.; Bonomo S.; Colabufo N. A.; Contino M.; Perrone M. G.; Fruttero R.; Gasco A.
New Selective COX-2 Inhibitors
2003-01-01 D. BOSCHI; CLARA CENA; ERIKA DEL GROSSO; STEFANO MORO; ALBERTO GASCO
New Uroselective NO-Donor a1-antagonists
2002-01-01 A. DI STILO; D. BOSCHI; E. MARINI; R. FRUTTERO; A. GASCO
NITRIC OXIDE DONOR DOXORUBICINS: A USEFUL STRATEGY TO ADDRESS THE PROBLEM OF MDR IN CANCER THERAPY
2012-01-01 Rolando B.; Riganti C.; Chegaev K.; Fruttero R.; Gasco A.
Nitrooxymethyl substituted analogues of Celecoxib and Rofecoxib
2007-01-01 BOSCHI D; CENA C; LAZZARATO L; MARINI E; FRUTTERO R.; GASCO A.
Nitrooxymethyl substituted analogues of celecoxib as potential antitumoral drugs with reduced cardiotoxicity
2008-01-01 Boschi D; Lazzarato L; Filieri A; Miglietta A; Bocca C; Fruttero R; Gasco A.
NO donor - melatonins: a new class of potential antiatherosclerosis agents
2005-01-01 CHEGAEV K; LAZZARATO L; GIORGIS M; CENA C; DI STILO A; FRUTTERO R; GASCO A; LUCINI V; PANNACI M
NO-donor Carnosine Derivatives As Potential Neuroprotective Agents
2011-01-01 Montanaro G.; Bertinaria M.; Giorgis M.; Rolando B.; Fruttero R.; Gasco A.
Titolo | Data di pubblicazione | Autore(i) | File |
---|---|---|---|
A multitarget approach to optimize the safety profile of coxibs: lumiracoxib derivatives with dual cyclooxygenase-2 inhibitor-thromboxane A2 receptor antagonist activity | 2013 | Malvina Hoxha; Valerie Capra; Carola Buccellati; Angelo Sala; Mohammed Abrar Abdul Gaffar Shaikh; Clara Cena; Roberta Fruttero; Alberto Gasco; G. Enrico Rovati; Massimo Bertinaria | |
Amphiphile NO-donor antioxidants as polivalent drugs | 2006 | MARINI E; LAZZARATO L; CHEGAEV K; FRUTTERO R; GASCO A | |
Aspects of heterocyclic chemistry in developing new 1,4-dihydropyridines Ca2+-agonists | 2000 | S.Visentin; G.Ermondi; D.Boschi; R. Fruttero; A. Gasco | |
Carnosine analogues containing Phenol substructures | 2012 | Giorgis M.; Bertinaria M.; Rolando B.; Montanaro G.; Fruttero R.; Gasco A. | |
CC1000: a new cardioprotective agent against ischemia/reperfusion injuries | 2006 | A. Di Stilo; R. Rastaldo; M. Giorgis; G. Losano; A. Gasco | |
Combined protective effect of nitric oxide donor and antioxidants in the rat heart | 2007 | Rastaldo R; Cappello S; Pagliaro P; Mancardi D; Di Stilo A; Gasco A; Losano G. | |
Different multitarget approaches to manage coxibs associatedcardiovascular risk. Design and synthesis of new lumiracoxibderivatives | 2012 | M. Bertinaria; M. A. A. G. Shaikh; C. Cena; B. Rolando; L. Lazzarato; R. Fruttero; A. Gasco; G. E. Rovati; C. Buccellati; V. Capra; A. Sala | |
Effetto del post-condizionamento farmacologico sui danni da ischemia e riperfusione | 2005 | Rastaldo R.; Di Stilo A.; Cappello S. ; Gasco F.; Pagliaro P.; Gasco A.; Losano G. | |
Multitarget Drugs: No-Donor Doxorubicins | 2015 | Chegaev, Konstantin; Riganti, Chiara; Gazzano, Elena; Rolando, Barbara; Fruttero, Roberta; Gasco, Alberto | |
Multitarget drugs: NO-donor doxorubicins | 2012 | Chegaev K.; Riganti C.; Rolando B.; Federico A.; Fruttero R.; Gasco A. | |
New analogues of Ca2+-channel activator Bay K8644 | 2003 | S. Visentin; F. Buonsanti; M. Novara; E. Carbone; A. Gasco | |
New NO-donor Bisphosphonates | 2001 | L. LAZZARATO; LOLLI M.L; DI STILO A; FRUTTERO R; GASCO A | |
New potent and selective P-gp inhibitors | 2013 | Guglielmo S.; Bonomo S.; Colabufo N. A.; Contino M.; Perrone M. G.; Fruttero R.; Gasco A. | |
New Selective COX-2 Inhibitors | 2003 | D. BOSCHI; CLARA CENA; ERIKA DEL GROSSO; STEFANO MORO; ALBERTO GASCO | |
New Uroselective NO-Donor a1-antagonists | 2002 | A. DI STILO; D. BOSCHI; E. MARINI; R. FRUTTERO; A. GASCO | |
NITRIC OXIDE DONOR DOXORUBICINS: A USEFUL STRATEGY TO ADDRESS THE PROBLEM OF MDR IN CANCER THERAPY | 2012 | Rolando B.; Riganti C.; Chegaev K.; Fruttero R.; Gasco A. | |
Nitrooxymethyl substituted analogues of Celecoxib and Rofecoxib | 2007 | BOSCHI D; CENA C; LAZZARATO L; MARINI E; FRUTTERO R.; GASCO A. | |
Nitrooxymethyl substituted analogues of celecoxib as potential antitumoral drugs with reduced cardiotoxicity | 2008 | Boschi D; Lazzarato L; Filieri A; Miglietta A; Bocca C; Fruttero R; Gasco A. | |
NO donor - melatonins: a new class of potential antiatherosclerosis agents | 2005 | CHEGAEV K; LAZZARATO L; GIORGIS M; CENA C; DI STILO A; FRUTTERO R; GASCO A; LUCINI V; PANNACI M | |
NO-donor Carnosine Derivatives As Potential Neuroprotective Agents | 2011 | Montanaro G.; Bertinaria M.; Giorgis M.; Rolando B.; Fruttero R.; Gasco A. |